In 2014, the outbreak of adenoviral pneumonia occurred in Korean military training center.
Introduction
Adenovirus (Adv) are non-enveloped, double-stranded DNA viruses and can present as upper and lower respiratory tract infection either in sporadic fashion or as epidemics.
Currently, 49 distinct Adv serotypes have been isolated from humans. Adv usually causes mild self-limited respiratory and gastrointestinal infection. Adv may case a variety of clinical manifestations, however, in immunocompromised patients, adenovirus infection leads to often fatal outcome. For example, in immunodeficiency states such as solid organ or stem cell transplantation, severe adenovirus infection may occur with mortality up to 80% [1] [2] [3] [4] .
Fatal adenovirus respiratory infection in immunocompromised patients has been described in several case reports or literatures. Adenoviral pneumonia is rare in the general population, but outbreaks have been occasionally reported in young adult women or military personnel [5] [6] [7] [8] [9] . Respiratory tract infection is the leading cause for hospitalization of military trainees in medical field. US military study showed that 10 % of recruits at boot camp were infected Adv, and 90% of patients with pneumonia were identified with adenovirus [10, 11] .
In 2006, a study from the South Korean military reported that prevalence of Adv was 61% among military recruits with acute respiratory symptoms [12] [13] [14] [15] [16] . Upper or lower respiratory tract infection of Adv may also progress to pneumonia. These days, several case series were reported that recruits in boot camp were death caused by severe adenoviral pneumonia in South Korea since 2012 [13, [15] [16] [17] . Even if the results of mortality or clinical outcome of Adv infection could be affected by selection bias, it is reported that Adv infection may be severe with higher incidence of progression to respiratory failure and multi-organ failure compared to other viral etiologies. Thus, some clinical data were reported to predictive factors of respiratory failure in Adv infection [18, 19] .
If Adv infection can be estimated early, increased monitoring and early applied organ support may improve clinical outcome of these patients, but there is no abundant data on distinctive characteristics in immunocompetent patients. We experienced that adenovirus positive CAP patients have high fever and different response to antipyretic treatment in other bacteria or virus positive CAP patients. Therefore, in this study, we aimed primarily to compare the clinical characteristics of Adv and Non-Adv positive CAP patients with immunocompetent military personnel and identified to distinctive findings.
Materials and Methods

Study design and definition
This study was a single center, retrospective cohort study. We reviewed the medical records of patients who were admitted to the Armed Forces Chuncheon Hospital (Gangwon The patients were included in this study when they 1) were admitted for treatment of CAP, 2) had virus polymerase chain reaction (PCR) tests performed on upper respiratory specimen. Exclusion criteria were as follows; 1) respiratory virus PCR test was not done, 2) they had incomplete records, 3) they were immediately transferred to tertiary hospital for advanced care, and 4) primary reason for admission was to manage co-morbid diseases.
CAP was defined using the definition set forth by Infectious Society of America/American Thoracic Society Consensus Guidelines [20] . In short, CAP was diagnosed when the patients had symptoms associated with respiratory tract infections and had new onset lung infiltration or pleural effusion on chest X-rays or chest computed tomography scans. We defined fever as any temperature greater than or equal to 38 degree Celsius recorded by tympanic route. All patients checked the body temperature every one hour at admission day. However, the body temperature was often measured within a 1 hour when patients had febrile sense or worsening signs of inflammation. We also recorded body temperature at the beginning of antipyretics administration. There was no standardized antipyretic treatment protocol for fever control. In our study, antipyretic therapy was administered upon reaching a body temperature ≥ 38 degree Celsius (°C). Interval of antipyretics administration was according to pharmacodynamics, however we performed additional antipyretics when patients had fever (two consecutive measurements ≥ 38°C) and deterioration of clinical symptoms including myalgia, general weakness, cough, nasal congestion, or dyspnea within 6 hours after antipyretics administration. Responsiveness to antipyretic treatment was classified as followed; complete response is body temperature drop below 38°C after antipyretics and sustained throughout, partial response is body temperature drop below 38°C but resurge during observation or need for additional antipyretics, and no response is body temperature sustained above or equal to 38°C after antipyretics use.
Unresponsive to initial antibiotic treatment was defined as had deterioration as evidenced by worsening of clinical symptoms signs and/or progression of lesions on radiologic studies after 48 to 72 hours of initial antibiotics treatment. 
Data collection and patient management
Results
Study participants
During the study period, a total of 445 cases of CAP patients admitted to the Armed Forces Chuncheon Hospital ( Figure. 1). All patients were admitted via emergency department.
Out of 445 cases, 194 cases were excluded. The reasons for exclusion were as follows; no respiratory virus PCR test in 170 patients, incomplete data in twenty patients, transferred to tertiary medical center within 72 hours in two patients, and admission for treatment of underlying diseases in two patients. Two patients who were admitted suspicious combined to underlying disease managed to acute asthma exacerbation. Consequently, 251 patients were enrolled this study. Among of them, patients with virus PCR positive for adenovirus (Adv group) were 67, and 184 with virus PCR negative for adenovirus (Non-Adv group). In NonAdv group patients, 50 patients were no identified pathogen in all culture study and 134 patients were identified other viruses, bacteria, and combined pathogens. 
Comparison of baseline characteristics
The results of laboratory and radiologic findings between Adv and Non-Adv group
We compared laboratory and radiologic findings between Adv and Non-Adv group (Table 2) . The percentage of patients having leukopenia and thrombocytopenia were higher in Adv patients (all p < 0.001), and leukocytosis was more common in Non-Adv group patients (p = 0.035). Infection markers, such as C-reactive protein (CRP) and procalcitonin were no difference between two groups. Also total bilirubin and creatinine showed no significant difference between two groups. Most common radiologic feature was ground glass opacity with consolidation in Adv groups and consolidation in Non-Adv group (p < 0.001). Unilateral distribution was dominant in both groups (83.5% vs 72.7%), however multi-lobar (≥ 3 lobes) involvement was more common in Non-Adv group (9.0% vs 22.3%, p = 0.015). Presence of pleural effusion was no significant difference between two groups.
Comparisons of fever and response to antipyretics
Figure 2 was presented to the alternation of mean body temperature at admission and during 7 days after admission between Adv and Non-Adv group patients. And also, we compared the fever and response to antipyretic treatment between Adv, Non-Adv, and no pathogen group in table 3. In generally, Adv group patients comparatively had much longer duration of fever after admission (3.2 ± 1.6 vs 1.9 ± 1.2, 2.2 ± 1.5 days, p = 0.018) and symptom onset (5.8 ± 2.2 vs 3.9 ± 2.5, 3.7 ± 2.0 days, p = 0.006). To evaluate the degree of fever, we check the mean body temperature and number of patients to maximal temperature at admission. Adv group patients had higher mean body temperature at admission (37.8 ± 0. 
Comparison of clinico-laboratory findings between Adv and Non-Adv group in patients with unresponsive to initial antibiotics treatment
Physician suspected of having atypical pathogens when patients had persistent or deteriorated symptoms or signs in despite of appropriate empirical antibiotics for 2-3 days.
Thus, we compared the clinico-laboratory findings between Adv and Non-Adv group patients with unresponsive to initial antibiotics treatment ( Table 4) . The number of patients who did not response to initial antibiotics treatment was 47 in Adv group and 50 in Non-Adv group.
The percentage of patients having leukocytosis and monocytopenia were higher in Adv patients, while there was no statistically difference in white blood cell and platelet count between two groups. Leukopenia and thrombocytopenia, which were statistically significant difference in all study patients, were no difference in patients with unresponsiveness to initial antibiotics treatment (p = 0.720, p = 0.733, respectively).
Adv group patients represented a higher in no response to antipyretic treatment compared with Non-Adv group patients (25.5% vs 10.0%, p = 0.045) and also more observed in number of patients to over 40 and 39 to 40 degree Celsius (p = 0.003). In addition, Adv group patients had higher mean body temperature at admission (37.8 ± 0.3 vs 37.3 ± 0.2, p = 0.005).
Comparison of treatment outcome
All patients received empirical antibiotics treatment (Table 5) ; a 3 rd generation cephalosporin plus and azithromycin was the most common regimen (n = 243, 96.8%), followed by piperacillin/ tazobactam plus respiratory quinolone (n = 5, 2.0%). The Change of antibiotics regimen was more frequently in Adv group patients (70.1% vs 27.2%, p = 0.024).
Duration of antibiotics had no significant difference between two groups. In our study, we did not perform to administration of cidofovir or adjuvant intravenous immunoglobulin (IVIG).
In addition, there were no patients who received mechanical ventilation or extracorporeal membrane oxygenation support.
At admission, mean dose of antipyretics was higher in Adv group patients (5.52 vs 4.30 gram, p = 0.032), however overall duration of antipyretics had no significant difference between two groups. In this study, we identified to adverse events after antipyretics administration such as hypotension, gastrointestinal trouble, skin rash, and elevated liver enzyme, and Adv group patients were commonly observed (p = 0.005).
Time to overall clinical stabilization from admission was significantly longer in the AdV group patients than in the Non-AdV group patients (4.3 ± 2.8 vs 2.9 ± 1.8 days, p = 0.034). Length of hospital stay had no significant difference between two groups and no patient died in our study.
Discussion
In our study, we described clinical characteristics of Adv positive community acquired pneumonia in immunocompetent military trainee patients. The most important findings were that Adv group patients had longer duration of fever after symptom onset and admission, higher mean body temperature at admission, higher number of patients had over 39°C at admission, longer duration of maximal falls in temperature at admission, and higher no response to antipyretic treatment at admission compared to Non-Adv group patients. In addition, leukopenia and thrombocytopenia were identified higher in Adv group patients, however in patients who unresponsiveness to initial antibiotics treatment, there were no difference between two groups.
There was some epidemiologic study of Adv in South Korea military trainees and personnel. Yoo et al. found that adenovirus was identified 33.0% of all specimens in febrile respiratory illness (FRI) or pneumonia patients [15] . In this study was a reviewed military patient with FRI or pneumonia that tested for respiratory viruses from October 2014 to May 2016. The proportion of patients with pneumonia and the hospitalization rate did not differ between those with and without adenovirus infection. However, adenovirus-infected patients had a significantly higher risk of requiring intensive care or mechanical ventilator support.
These notable findings mean that adenovirus infection has been occasionally associated with mortality and morbidity with loss in combat strength and increasing in cost of care.
To date, there was rarity data on characteristics of fever in Adv infection, especially in immunocompetent patients. We compared the characteristics of fever in Adv and Non-Adv group patients. Adv group patients had longer duration of fever and higher proportion of peak body temperature than other various viral respiratory infected or no pathogen group patients.
Somewhile, Ho and colleagues [22] found that viral mono-pathogen patients had higher mean body temperature than bacterial mono-pathogen patients. In addition, dual-pathogen patients, such as Streptococcus pneumoniae with either influenza A or B, had higher mean body temperature, although these were not significant different from respective mono-pathogens.
However, there is still lack of data on the detailed specific pathogen related clinical characteristic such as fever in immunocompetent patients. Thus, our data would be more likely to help to provide the physician to determine further diagnostic or therapeutic consideration at the time of admission.
We also referred to response to antipyretic treatment between Adv and Non-Adv group patients. Our data showed that Adv group patients represented a higher proportion of no response to antipyretic treatment compared with Non-Adv or no pathogen group patients.
Weisse et al. mainly deal with effect of acetaminophen on fever in bacterial vs viral infection was tested in 100 children [23] . They concluded that there is no correlation between a fever response to acetaminophen and the etiology of the fever so no usefulness of response to antipyretic treatment in predicting etiologies of pneumonia. However, our data suggest that there may be difference in antipyretic response to AdV compared to other etiologies and this is first data on immunocompetent adults.
Our study had several limitations. First, our study was retrospective design in single center, so confounding variables, for example antibiotics regimen or inconsistent timing of antipyretics administration, might be had possible effects of clinical course of fever or response to antipyretic treatment. Second, our study had shortly reflect to unmeasurable variables, such as genotype of adenovirus, so difference in severity of illness between AdV vs.
Non-AdV might be led to difference in characteristics of fever and its response to antipyretics.
Third, we conducted our study in military hospital, so our cohort was not represent to general population because military environment had different condition such as living environment, nutrition/immune status, and mode of pathogen spread. Forth, the reason is selection bias that all patients admitted with CAP could not performed the respiratory PCR test, the examination limited to an upper respiratory tract, and did not performed Adv serotype or viral burden.
Conclusions
To the best of our knowledge, this study is the first to analyze characteristics of fever and response to antipyretic therapy in immunocompetent adult patients with adenovirus infected CAP. A significant difference of patients with Adv group have some clinical characteristics that longer duration of fever, high fever (over 39 degree Celsius), and higher proportion of no response to antipyretic treatment at admission compared to Non-Adv group at this study. 
